Cover Image
Market Research Report

Asia Pacific Pregnancy & Ovulation Testing Market Research Report: By Type, by Mode of Purchase, End-User - Global Forecast Till 2023

Published by Market Research Future Product code 781825
Published Content info 172 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia Pacific Pregnancy & Ovulation Testing Market Research Report: By Type, by Mode of Purchase, End-User - Global Forecast Till 2023
Published: January 31, 2019 Content info: 172 Pages
Description

Introduction

Pregnancy testing is the detection of human Chorionic Gonadotropin (hCG) in both urine and serum as early as seven to 10 days after conception, whereas, ovulation testing detects the Luteinizing Hormone (LH) level. The declining fertility rate, the emergence of highly accurate advanced technology, and easy availability of ovulation and pregnancy monitors are expected to drive market growth. For instance, according to the statistics presented by the World Bank, India had a fertility rate of 3.311 in 2000 whereas in 2016 it declined to 2.326. However, the high costs associated with ovulation tests may hamper the growth of the market.

The Asia-Pacific pregnancy and ovulation testing market is expected to reach a market value of USD 298.68 million by 2023 from USD 209.37 million in 2017 and is expected to register a CAGR of 6.10% during the forecast period from 2018 to 2023. In 2017, the market was led by Japan with a 23.2% share, followed by China and India with shares of 22.5% and 19.7%, respectively. The growing demand for pregnancy testing has been observed in different parts of the world which fuels the growth of the market.

The Asia-Pacific pregnancy and ovulation testing market is segmented by product type, mode of purchase, end user, and country.

The Asia-Pacific pregnancy and ovulation testing market, by product type, is segmented into pregnancy testing (hCG detection) and ovulation testing.

The Asia-Pacific pregnancy and ovulation testing market, by pregnancy testing (hCG detection), is further segmented into urine-based testing and blood-based testing.

The Asia-Pacific pregnancy and ovulation testing market, by ovulation testing, is sub-segmented into ovulation prediction kits and fertility monitors.

The Asia-Pacific pregnancy and ovulation testing market, by mode of purchase, is segmented into non-prescription or OTC testing and prescription testing.

The Asia-Pacific pregnancy and ovulation testing market, by end user, is segmented into hospitals and clinics, fertility centers, and others.

Key Players

SPD Swiss Precision Diagnostics GmbH, Fairhaven Health LLC, Church & Dwight Co. Inc., Piramal Enterprises Ltd, Quidel Corporation, Mankind Pharma Ltd, TaiDoc Technology & Corporation, Cadila Healthcare Limited, Gregory Pharmaceutical Holdings Inc., and others

Study Objectives

  • To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the Asia-Pacific pregnancy and ovulation testing market
  • To provide insights into factors affecting the market growth
  • To analyze the Asia-Pacific pregnancy and ovulation testing market based on various tools such as value chain analysis and Porter's five force analysis
  • To provide historical and forecast revenue of market segments and sub-segments with respect to respective key countries
  • To provide country-level analysis of the market with respect to current market size and future perspective
  • To provide country-level analysis of the market for segments by product type, by mode of purchase, and by end user.
  • To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Asia-Pacific pregnancy and ovulation testing market

Target Audience

  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Clinics
  • Hospitals
  • Research and Development (R&D) Companies
  • Government Research Institutes
  • Academic Institutes and Universities

Key Findings

  • The Asia-Pacific pregnancy and ovulation testing market is expected to reach USD 298.68 million by 2023 from USD 209.37 million in 2017 and is expected to register a CAGR of 6.10% during the forecast period from 2018 to 2023
  • On the basis of product type, the pregnancy testing (hCG detection) segment is expected to account for the largest market share at a CAGR of 5.95% by 2023
  • Based on mode of purchase, the non-prescription or OTC testing segment is expected to account for the largest market share at a CAGR of 6.0% by 2023
  • Based on end user, the hospitals and clinics segment is expected to account for the largest market share at a CAGR of 5.78% by 2023
  • Japan is expected to hold the largest share of the Asia-Pacific pregnancy and ovulation testing market at a CAGR of 23.2% by 2023

Regional Analysis

  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Republic of Korea
    • Rest of Asia-Pacific
Table of Contents

Table of Contents

1 Report Prologue

2 Executive Summary

3 Market Introduction

  • 3.1 Definition
  • 3.2 Scope of the Study
  • 3.3 Assumptions & Limitations
    • 3.3.1 Assumptions
    • 3.3.2 Limitations
  • 3.4 Market Structure

4 Research Methodology

  • 4.1 Research Process
  • 4.2 Primary Research
  • 4.3 Secondary Research
  • 4.4 Market Size Estimation

5 Market Dynamics

  • 5.1 Introduction
  • 5.2 Drivers
    • 5.2.1 Declining Fertility Rate
    • 5.2.2 Emergence of Advanced Technology with High Accuracy
    • 5.2.3 Easy availability of ovulation & pregnancy monitors on e-commerce websites
  • 5.3 Restraints
    • 5.3.1 High cost associated with ovulation tests
  • 5.4 Opportunities
    • 5.4.1 Growing awareness about pregnancy and ovulation testing

6 Market Factor Analysis

  • 6.1 Porter's Five Forces Analysis
    • 6.1.1 Bargaining Power of Suppliers
    • 6.1.2 Bargaining Power of Buyers
    • 6.1.3 Threat of New Entrants
    • 6.1.4 Threat of Substitutes
    • 6.1.5 Intensity of Rivalry
  • 6.2 Supply Chain Analysis
    • 6.2.1 R&D
    • 6.2.2 Parts Manufacturing
    • 6.2.3 Distribution
    • 6.2.4 Marketing & Sales
    • 6.2.5 Post-Sales Monitoring
  • 6.3 Pricing Analysis
  • 6.4 Investment Opportunities

7 Asia Pacific Pregnancy & Ovulation Testing Market, by Product Type

  • 7.1 Overview
    • 7.1.1 Introduction
    • 7.1.2 Pregnancy Testing (hCG Detection)
      • 7.1.2.1 Urine-based Testing
      • 7.1.2.2 Blood-based Testing
    • 7.1.3 Ovulation Testing
      • 7.1.3.1 Ovulation Prediction Kits
      • 7.1.3.2 Fertility Monitors

8 Asia Pacific Pregnancy & Ovulation Testing Market, by Mode of Purchase

  • 8.1 Overview
    • 8.1.1 Introduction
    • 8.1.2 Non-prescription or OTC Testing
    • 8.1.3 Prescription Testing

9 Asia Pacific Pregnancy & Ovulation Testing Market, by End-User

  • 9.1 Overview
    • 9.1.1 Introduction
    • 9.1.2 Hospitals & Clinics
    • 9.1.3 Fertility Centres
    • 9.1.4 Others

10 Asia Pacific Pregnancy & Ovulation Testing Market, by Country/Region

  • 10.1 Asia Pacific
    • 10.1.1 Japan
    • 10.1.2 China
    • 10.1.3 India
    • 10.1.4 Republic of Korea
    • 10.1.5 Australia
    • 10.1.6 Rest of Asia Pacific

11 Competitive Landscape

  • 11.1 Introduction
  • 11.2 Company Share Analysis

12 Company Profiles

  • 12.1 SPD Swiss Precision Diagnostics GmbH
    • 12.1.1 Company Overview
    • 12.1.2 Financial Overview
    • 12.1.3 Products Offering
    • 12.1.4 Key Developments
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Strategy
  • 12.2 Fairhaven Health, LLC
    • 12.2.1 Company Overview
    • 12.2.2 Financial Overview
    • 12.2.3 Products Offering
    • 12.2.4 Key Developments
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Strategy
  • 12.3 Church & Dwight Co., Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Financial Overview
    • 12.3.3 Products Offering
    • 12.3.4 Key Developments
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Strategy
  • 12.4 Piramal Enterprises Ltd.
    • 12.4.1 Company Overview
    • 12.4.2 Financial Overview
    • 12.4.3 Products Offering
    • 12.4.4 Key Developments
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Strategy
  • 12.5 Quidel Corporation
    • 12.5.1 Company Overview
    • 12.5.2 Financial Overview
    • 12.5.3 Products Offering
    • 12.5.4 Key Developments
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Strategy
  • 12.6 Mankind Pharma Ltd.
    • 12.6.1 Company Overview
    • 12.6.2 Financial Overview
    • 12.6.3 Products Offering
    • 12.6.4 Key Developments
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Strategy
  • 12.7 TaiDoc Technology & Corporation
    • 12.7.1 Company Overview
    • 12.7.2 Financial Overview
    • 12.7.3 Products Offering
    • 12.7.4 Key Developments
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Strategy
  • 12.8 Cadila Healthcare Limited
    • 12.8.1 Company Overview
    • 12.8.2 Financial Overview
    • 12.8.3 Products Offering
    • 12.8.4 Key Developments
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Strategy
  • 12.9 Gregory Pharmaceutical Holdings, Inc.
    • 12.9.1 Company Overview
    • 12.9.2 Financial Overview
    • 12.9.3 Products Offering
    • 12.9.4 Key Developments
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Strategy

13 Appendix

  • 13.1 Discussion Blue Print
  • 13.2 References

List of Tables

  • TABLE 1 MARKET SYNOPSIS
  • TABLE 2 PRIMARY INTERVIEWS
  • TABLE 3 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 4 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR PREGNANCY TESTING (HCG DETECTION), BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 5 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR PREGNANCY TESTING (HCG DETECTION), BY COUNTRY/REGION, 2015-2023 (USD MILLION)
  • TABLE 6 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR URINE-BASED TESTING, BY COUNTRY/REGION, 2015-2023 (USD MILLION)
  • TABLE 7 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR BLOOD-BASED TESTING, BY COUNTRY/REGION, 2015-2023 (USD MILLION)
  • TABLE 8 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR OVULATION TESTING, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 9 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 10 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR OVULATION TESTING, BY COUNTRY/REGION, 2015-2023 (USD MILLION)
  • TABLE 11 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR OVULATION PREDICTION KITS, BY COUNTRY/REGION, 2015-2023 (USD MILLION)
  • TABLE 12 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY COUNTRY/REGION, 2015-2023 (USD MILLION)
  • TABLE 13 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET BY MODE OF PURCHASE, 2015-2023 (USD MILLION)
  • TABLE 14 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR NON-PRESCRIPTION OR OTC TESTING, BY COUNTRY/REGION, 2015-2023 (USD MILLION)
  • TABLE 15 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR PRESCRIPTION TESTING, BY COUNTRY/REGION, 2015-2023 (USD MILLION)
  • TABLE 16 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 17 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY/REGION, 2015-2023 (USD MILLION)
  • TABLE 18 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY CENTRES, BY COUNTRY/REGION, 2015-2023 (USD MILLION)
  • TABLE 19 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY COUNTRY/REGION, 2015-2023 (USD MILLION)
  • TABLE 20 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 21 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY PREGNANCY TESTING TYPE, 2015-2023 (USD MILLION)
  • TABLE 22 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY OVULATION TESTING TYPE, 2015-2023 (USD MILLION)
  • TABLE 23 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 24 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2015-2023 (USD MILLION)
  • TABLE 25 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 26 JAPAN: PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 27 JAPAN: PREGNANCY & OVULATION TESTING MARKET, BY PREGNANCY TESTING TYPE, 2015-2023 (USD MILLION)
  • TABLE 28 JAPAN: PREGNANCY & OVULATION TESTING MARKET, BY OVULATION TESTING TYPE, 2015-2023 (USD MILLION)
  • TABLE 29 JAPAN: PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 30 JAPAN: PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2015-2023 (USD MILLION)
  • TABLE 31 JAPAN: PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 32 CHINA: PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 33 CHINA: PREGNANCY & OVULATION TESTING MARKET, BY PREGNANCY TESTING TYPE, 2015-2023 (USD MILLION)
  • TABLE 34 CHINA: PREGNANCY & OVULATION TESTING MARKET, BY OVULATION TESTING TYPE, 2015-2023 (USD MILLION)
  • TABLE 35 CHINA: PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 36 CHINA: PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2015-2023 (USD MILLION)
  • TABLE 37 CHINA: PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 38 INDIA: PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 39 INDIA: PREGNANCY & OVULATION TESTING MARKET, BY PREGNANCY TESTING TYPE, 2015-2023 (USD MILLION)
  • TABLE 40 INDIA: PREGNANCY & OVULATION TESTING MARKET, BY OVULATION TESTING TYPE, 2015-2023 (USD MILLION)
  • TABLE 41 INDIA: PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 42 INDIA: PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2015-2023 (USD MILLION)
  • TABLE 43 INDIA: PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 44 REPUBLIC OF KOREA: PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 45 REPUBLIC OF KOREA: PREGNANCY & OVULATION TESTING MARKET, BY PREGNANCY TESTING TYPE, 2015-2023 (USD MILLION)
  • TABLE 46 REPUBLIC OF KOREA: PREGNANCY & OVULATION TESTING MARKET, BY OVULATION TESTING TYPE, 2015-2023 (USD MILLION)
  • TABLE 47 REPUBLIC OF KOREA: PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 48 REPUBLIC OF KOREA: PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2015-2023 (USD MILLION)
  • TABLE 49 REPUBLIC OF KOREA: PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 50 AUSTRALIA: PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 51 AUSTRALIA: PREGNANCY & OVULATION TESTING MARKET, BY PREGNANCY TESTING TYPE, 2015-2023 (USD MILLION)
  • TABLE 52 AUSTRALIA: PREGNANCY & OVULATION TESTING MARKET, BY OVULATION TESTING TYPE, 2015-2023 (USD MILLION)
  • TABLE 53 AUSTRALIA: PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 54 AUSTRALIA: PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2015-2023 (USD MILLION)
  • TABLE 55 AUSTRALIA: PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 56 REST OF ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 57 REST OF ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY PREGNANCY TESTING TYPE, 2015-2023 (USD MILLION)
  • TABLE 58 REST OF ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY OVULATION TESTING TYPE, 2015-2023 (USD MILLION)
  • TABLE 59 REST OF ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET FOR FERTILITY MONITORS, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 60 REST OF ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2015-2023 (USD MILLION)
  • TABLE 61 REST OF ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2015-2023 (USD MILLION)

List of Figures

  • FIGURE 1 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET: MARKET STRUCTURE
  • FIGURE 2 RESEARCH PROCESS
  • FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 4 MARKET DYNAMICS ANALYSIS OF ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET
  • FIGURE 5 PORTERS FIVE FORCES ANALYSIS OF ASIA PACIFIC PREGNANCY AND OVULATION TESTING MARKET
  • FIGURE 6 SUPPLY CHAIN: ASIA PACIFIC PREGNANCY AND OVULATION TESTING MARKET
  • FIGURE 7 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2017 (% SHARE)
  • FIGURE 8 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET, BY PRODUCT TYPE, 2017 & 2023 (USD MILLION)
  • FIGURE 9 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2017 (% SHARE)
  • FIGURE 10 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET, BY MODE OF PURCHASE, 2017 & 2023 (USD MILLION)
  • FIGURE 11 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2017 (% SHARE)
  • FIGURE 12 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET, BY END-USER, 2017 & 2023 (USD MILLION)
  • FIGURE 13 ASIA PACIFIC: PREGNANCY & OVULATION TESTING MARKET SHARE, BY COUNTRY/REGION, 2017 (%)
  • FIGURE 14 ASIA PACIFIC PREGNANCY & OVULATION TESTING MARKET, MARKET SHARE ANALYSIS 2017 (%)
Back to Top